Effects of first- and second-generation tyrosine kinase inhibitor therapy on glucose and lipid metabolism in chronic myeloid leukemia patients: a real clinical problem?

MLA

Iurlo, Alessandra, et al. “Effects of First- and Second-Generation Tyrosine Kinase Inhibitor Therapy on Glucose and Lipid Metabolism in Chronic Myeloid Leukemia Patients: A Real Clinical Problem?” Oncotarget, vol. 6, no. 32, Oct. 2015, pp. 33944–51. EBSCOhost, https://doi.org/10.18632/oncotarget.5580.

APA

Iurlo, A., Orsi, E., Cattaneo, D., Resi, V., Bucelli, C., Orofino, N., Sciumè, M., Elena, C., Grancini, V., Consonni, D., Orlandi, E. M., & Cortelezzi, A. (2015). Effects of first- and second-generation tyrosine kinase inhibitor therapy on glucose and lipid metabolism in chronic myeloid leukemia patients: a real clinical problem? Oncotarget, 6(32), 33944–33951. https://doi.org/10.18632/oncotarget.5580

Chicago

Iurlo, Alessandra, Emanuela Orsi, Daniele Cattaneo, Veronica Resi, Cristina Bucelli, Nicola Orofino, Mariarita Sciumè, et al. 2015. “Effects of First- and Second-Generation Tyrosine Kinase Inhibitor Therapy on Glucose and Lipid Metabolism in Chronic Myeloid Leukemia Patients: A Real Clinical Problem?” Oncotarget 6 (32): 33944–51. doi:10.18632/oncotarget.5580.